Health authorities in the UK have renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) and recommended annual health checks as part of efforts to improve diagnosis and long-term management of the condition. The National Institute for Health and Care Excellence (NICE) published draft guidance earlier this year recommending annual reviews for women with PMOS to monitor symptoms, treatment, and longer-term health risks, with final guidance expected on 27 January.
Proponents of the renaming argue that the new terminology better reflects the complexity of the condition, which affects millions of women and can impact hair growth, periods, fertility, and mood. Clinical experts describe PMOS as a cardiometabolic condition affecting multiple organ systems rather than solely a gynecological issue. Dr. Rima Smith, clinical associate professor of reproductive medicine at Birmingham Women’s Hospital, noted that the condition had never been accurately captured by its previous name and emphasized the need for holistic care involving diabetes, thyroid, and menstrual function checks.
Women living with the condition have highlighted significant gaps in current care. Neelam Heera-Shergill, who was diagnosed at age 18 and later founded the charity Cysters to address inequalities in menstrual and maternal health, described receiving minimal guidance after her diagnosis. Similarly, Rochelle Lewis reported that her concerns about PMOS were initially dismissed by healthcare providers before she received a diagnosis in 2025. Both women emphasized that while the renaming and annual review recommendations represent progress, more comprehensive systemic changes are needed to ensure women receive adequate support and holistic care following diagnosis.
Clinical advisers stressed that annual reviews should involve a comprehensive assessment rather than focusing narrowly on weight management or single interventions. The recommendations aim to improve consistency of care across the healthcare system, increase awareness of the condition, and support earlier diagnosis and management for women experiencing symptoms associated with PMOS.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI